Author

Daniel Aaron

  • Behavioral Health

    Ohio’s Efforts to Centralize Control Over Opioid Claims

    By Daniel Aaron On October 21, two Ohio counties are slated to present their opioid claims in a federal trial. However, last week, 13 states and the District of Columbia signed onto a brief requesting…

    Ohio’s Efforts to Centralize Control Over Opioid Claims

    Ohio state flags waving in front of the Ohio State House
  • Behavioral Health

    The Role of Attorneys General in the Opioid Litigation

    By Daniel Aaron People following the opioid lawsuits might have noticed some strange headlines as of late. Virtually every state’s attorney general (AG) is suing Purdue Pharmaceuticals, maker of the blockbuster drug OxyContin. Purdue filed…

    The Role of Attorneys General in the Opioid Litigation

    Photograph of Purdue Pharma headquarters
  • FDA

    FDA’s Warning Letter to Juul & the First Amendment

    By Daniel Aaron On September 10, 2019, the Food and Drug Administration (FDA) issued a warning letter to Juul asserting that the vaping manufacturer had violated federal law by illegally marketing its e-cigarettes as safer…

    FDA’s Warning Letter to Juul & the First Amendment

    Photograph of a person holding an e-cigarette in one hand and traditional cigarettes in the other hand.